Individualized and fine-tuned treatment
The medical company that has developed an innovative system for individualized dosing of tablets.
Sensidose AB is a pharmaceutical company that has developed a system for individualized dosing of tablets, a medical treatment using a dosing device pre-programmed for the patient. The system consists of tablets, containing low dose in each individual tablet. The correct dose is obtained by dosing a specific number of tablets. The tablets are dispensed using an electronic dispenser, programmed by the healthcare provider. The dispenser has a built-in alarm, delivers doses at the preset times and registers all doses delivered and also disease symptoms using rating scales that are easy to use. The company’s technology does not affect the course of the disease but treats the symptoms of the disease.
The idea for Sensidose’s treatment strategy came about already in the mid-1990s when professors Sten-Magnus Aquilonius and Christer Nyström realized that it would be possible to personalise Parkinson’s treatment with microtablets. Today, the company’s drug Flexilev...
Pharma company Sensidose has recruited Philip Slätis as Chief Operating Officer and Deputy CEO. Slätis takes on on his role on November 1 and brings broad experience from the pharmaceutical industry. He is expected to contribute to the company’s business development...
Sensidose reinforces its management. Philip Slätis has been hired as Chief Operating Officer and Deputy CEO of Sensidose AB. Philip will take up the position on 1st November in 2022
Sollentuna 1:a September 2022 Sensidose reinforces its management. Philip Slätis has been hired as Chief Operating Officer and Deputy CEO of Sensidose AB. Philip will take up the position on 1st November in 2022. - Philips' broad experience from all parts of the...
MyFID is a programmable dosing device for tablets. By combining the possibilities of a modern technology and tablets with a smaller amount of active ingredients, a fine-tuned dosing can be achieved. By choosing a number of tablets a specific, individualized dose can be arrived.
MyFID is pre-programmed to deliver a certain amount of medicine at a certain time. The physician decides which dose a patient should use and when it should be taken. However in order for the device not to rule the user’s life, care has been taken to ensure that the user choose which functions of the device that should be active.
MyFID has unique registration capabilities. It registers the amount and time a dose is delivered. MyFID will ask and record reasons why a dose is taken. It also records disease symptoms using easy to use scales that allows for the patient and the doctor to follow treatment effects, to get a continuous picture of how the disease evolves and fluctuates with time.
All information recorded is available for both the user and the physician, and can be retrieved using an inbuilt standardized treatment report. MyFID therefore gives the physician and the patient a more precise and correct background for further treatment decisions.
Flexilev is prescribed to you by a doctor who knows how to treat Parkinson’s disease. Before you start the treatment, it is good to know a little about the treatment that takes place with the help of a dispensing machine. It is important to take Flexilev at every prescribed dose at the doctor’s recommendation. It increases the chance of regular symptom relief.
Flexilev is a prescription drug in the form of small “micro-tablets” that are taken with the help of a dose dispenser, MyFID. The dose dispenser, which can be programmed by your doctor or nurse, delivers a certain number of tablets at each dosing time.
Org. Nr. 556550-3074
Vetenskapsvägen 10 191 38 Sollentuna
Tel : 010 – 70 77 380
191 38 Sollentuna, Sverige